Matching slides 110,471
Current window 87,451-87,480
Pages 3,683
Rows per page 30
Component: Listclear collectionreset all

Component

87,451-87,480 of 110,471

filter-aware
12
Aeglea BioTherapeutics | Investor Presentation Deck | 37 slidesAeglea BioTherapeutics | Investor Presentation Deck | 37 slides · Aeglea BioTherapeutics
Pitch deck Investor relations Beat · Solution1 hit
19
The slide uses a heatmap to visualize individual patient outcomes, highlighting clinical improvement vs. worsening.Aeglea BioTherapeutics | Investor Presentation Deck | 37 slides · Aeglea BioTherapeutics
Pitch deck Investor relations Loop · Jobs To Be Done1 hit
20
Clinical trial safety data comparing Pegzilarginase to Placebo.Aeglea BioTherapeutics | Investor Presentation Deck | 37 slides · Aeglea BioTherapeutics
Pitch deck Investor relations Loop · Jobs To Be Done1 hit
26
The chart shows a clear dose-response relationship where the 10.0 mg/kg dose achieves a more significant and sustained reduction in tHcy compared to the 1.0 mg/kg dose.Aeglea BioTherapeutics | Investor Presentation Deck | 37 slides · Aeglea BioTherapeutics
Pitch deck Investor relations 1 hit
31
Box plot visualization of clinical trial results.Aeglea BioTherapeutics | Investor Presentation Deck | 37 slides · Aeglea BioTherapeutics
Pitch deck Investor relations 1 hit
03
Alkermes | Results Presentation Deck | 21 slidesAlkermes | Results Presentation Deck | 21 slides · Alkermes
Conference presentation Investor relations Beat · Attention1 hit
07
The slide includes a disclaimer regarding the date of the expectations and a note about non-GAAP reconciliation.Alkermes | Results Presentation Deck | 21 slides · Alkermes
Conference presentation Investor relations Beat · Need1 hit
10
Alkermes | Results Presentation Deck | 21 slidesAlkermes | Results Presentation Deck | 21 slides · Alkermes
Conference presentation Investor relations Beat · Need1 hit
13
The chart includes a vertical dashed line separating 2021 from 2022.Alkermes | Results Presentation Deck | 21 slides · Alkermes
Conference presentation Investor relations Beat · Need1 hit
15
Alkermes | Results Presentation Deck | 21 slidesAlkermes | Results Presentation Deck | 21 slides · Alkermes
Conference presentation Investor relations Beat · SatisfactionLoop · Cost Of Inaction1 hit
04
The slide uses a circular graphic to emphasize the 'revolution' theme and highlights the company's focus on targeted treatment modalities.argenx SE | Investor Presentation Deck | 22 slides · argenx
Conference presentation Investor relations Beat · WhatLoop · Golden Circle1 hit
05
The slide uses a circular photo collage of patients to emphasize the human element of the treatment goals.argenx SE | Investor Presentation Deck | 22 slides · argenx
Conference presentation Investor relations Beat · WhatLoop · Golden Circle1 hit
08
The slide uses a three-column layout for clinical data and a footer for scientific validation.argenx SE | Investor Presentation Deck | 22 slides · argenx
Conference presentation Investor relations Beat · HowLoop · Golden Circle1 hit
13
The slide uses a timeline structure to map clinical development stages against specific disease indications and their associated U.S. patient prevalence numbers.argenx SE | Investor Presentation Deck | 22 slides · argenx
Conference presentation Investor relations Beat · HowLoop · Golden Circle1 hit
14
The slide highlights the mechanism of action (sweeping antibody) and the clinical pipeline status for MMN, delayed graft function, and dermatomyositis.argenx SE | Investor Presentation Deck | 22 slides · argenx
Conference presentation Investor relations Beat · HowLoop · Golden Circle1 hit
22
The slide outlines a multi-stage clinical trial process including an open-label phase followed by a placebo-controlled relapse-based study.argenx SE | Investor Presentation Deck | 22 slides · argenx
Conference presentation Investor relations 1 hit
10
The timeline is segmented into three horizontal tracks: Van Production, Other Operations, and Corporate & Legislative.Arrival | SPAC Presentation Deck | 21 slides · Arrival
Pitch deck Investment bank Loop · Why Now1 hit
12
The slide uses a bubble-within-a-bubble chart to visualize market size and a list of key drivers for profitability.Arrival | SPAC Presentation Deck | 21 slides · Arrival
Pitch deck Investment bank Beat · Market Size1 hit
23
The slide uses a visual layout contrasting production imagery with key operational metrics.Astra | Investor Presentation Deck | 63 slides · Astra
Pitch deck Investor relations Beat · SolutionLoop · Cost Of Inaction1 hit
24
Astra | Investor Presentation Deck | 63 slidesAstra | Investor Presentation Deck | 63 slides · Astra
Pitch deck Investor relations 1 hit
25
The slide uses a split-layout with visual examples of the software on the left and key value propositions on the right.Astra | Investor Presentation Deck | 63 slides · Astra
Pitch deck Investor relations 1 hit
48
The slide features a high-quality photo of the engine hardware alongside key performance metrics.Astra | Investor Presentation Deck | 63 slides · Astra
Pitch deck Investor relations 1 hit
50
The slide uses a 3D render with callouts to label key hardware components.Astra | Investor Presentation Deck | 63 slides · Astra
Pitch deck Investor relations 1 hit
05
The slide is divided into two main sections: a definition of IO and a description of the company's specific research and development focus areas.AstraZeneca | Investor Conference Presentation Deck | 20 slides · AstraZeneca
Conference presentation Investor relations Beat · InterestLoop · Cost Of Inaction1 hit
08
The slide uses a combination of technical explanation and a process diagram to define the technology.AstraZeneca | Investor Conference Presentation Deck | 20 slides · AstraZeneca
Conference presentation Investor relations Beat · SatisfactionLoop · Jobs To Be Done1 hit
09
Includes a testimonial from Puja Sapra and a list of pipeline assets.AstraZeneca | Investor Conference Presentation Deck | 20 slides · AstraZeneca
Conference presentation Investor relations Beat · SatisfactionLoop · Jobs To Be Done1 hit
13
Includes a quote from Mark Cobbold and a list of pipeline assets.AstraZeneca | Investor Conference Presentation Deck | 20 slides · AstraZeneca
Conference presentation Investor relations Beat · Satisfaction1 hit
16
Includes a quote from Stephen Fawell and a diagram illustrating epigenetic mechanisms (histone modification, DNA methylation, RNA interference).AstraZeneca | Investor Conference Presentation Deck | 20 slides · AstraZeneca
Conference presentation Investor relations Beat · Satisfaction1 hit
06
The slide uses a horizontal stacked bar chart format to visualize revenue composition.AstraZeneca | Results Presentation Deck | 41 slides · AstraZeneca
Conference presentation Investor relations Beat · Need1 hit
07
The slide uses a progress-tracking visual to show specific drug candidates and their trial names/indications.AstraZeneca | Results Presentation Deck | 41 slides · AstraZeneca
Conference presentation Investor relations Beat · Need1 hit